India consults on national policy to promote, protect local medical device industry
This article was originally published in SRA
The Indian government is inviting feedback on its first ever national-level policy on medical devices that aims to support the domestic medtech industry through a variety of measures, such as by creating a separate National Medical Device Authority (NMDA), changing the tax/duty structure to promote and protect local device companies, and creating a separate regulator for medtech pricing issues1.
You may also be interested in...
India will finally get a device-specific regulatory framework when new rules formed by the government come into force next year. While the medtech industry has welcomed this long-awaited development, it hopes that its outstanding concerns will be addressed before the rules come into play.
Saudi Arabia has explained what information on a drug’s review will be made public following a marketing authorization decision.
Revised labeling requirements for unauthorized investigational and auxiliary medicinal products under the EU Clinical Trial Regulation have been published in the Official Journal.